Direktorat Registrasi ObatValid

GEMTAVIS

Claim this product
BPOM Number
DKI1729200780A1
Approved
21 November 2024
Expiry
24 September 2026
Form
SERBUK INJEKSI LIOFILISASI; 228 MG

About This Registration

GEMTAVIS is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1729200780A1. Its current registration status is Valid, with the licence valid until 24 September 2026. The product is registered to ACTAVIS INDONESIA - INDONESIA. BPOM first approved this registration in September 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 200 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

GEMCITABINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
ACTAVIS INDONESIA - INDONESIA holds 164 BPOM registrations
Manufacturer Scale
ACTAVIS INDONESIA - INDONESIA produces 164 registered products
Registration Age
Registered for 5 years
Expiry Status
Expired 2 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1